Substance / Medication

Tolbutamide sodium

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

903 trials linked to this intervention

903
Total Trials
103
Recruiting
282
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Model-Based Meta-Analysis of the Relationship Between Pioglitazone and Histological Outcomes in Metabolic Dysfunction-Associated Steatohepatitis Patients.
Tran Quyen Thi, Bui Tham Thi, Ngo Lien Thi et al. · CPT Pharmacometrics Syst Pharmacol · 2026
PMID: 40248984Meta-AnalysisFull text (PMC)
Prevalence of congenital anomalies in pregnancies complicated by type 2 diabetes: Systematic review and meta-analysis.
Oppermann Maria Lúcia R, Campos Maria Amélia A, Guerra Giulia L et al. · Int J Gynaecol Obstet · 2026
PMID: 40682407Meta-Analysis
Intensive Blood Pressure Control in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular and Microvascular Outcomes.
Mousavi Asma, Shojaei Shayan, Abhari Amir Parsa et al. · Am J Hypertens · 2026
PMID: 40717314Meta-Analysis
The Effect of SGLT2 Inhibitors on Blood Pressure in Relation to Baseline Kidney Function: A Systematic Literature Review and Data Analysis.
Møller Charlotte Agergaard, Nielsen Steffen Flindt, Mose Frank Holden · Am J Hypertens · 2026
PMID: 40717316Meta-Analysis
A meta-analysis of available data of the effects of selected whole and powdered fruits on glycemia in type 2 diabetes.
Kuramoto Nozomi, Hironaka Junya, Okada Hiroshi et al. · Am J Med · 2026
PMID: 40819727Meta-Analysis
Effect of Tirzepatide on the Risk of Developing Type 2 Diabetes Mellitus Among the People Living With Obesity or Overweight: A Systematic Review.
Pardeshi Geeta, Kumbhar Uddhav T, Kaviprawin Mogan et al. · Clin Obes · 2026
PMID: 40832978Meta-Analysis
Transtheoretical Model-based Dietary and Exercise Interventions for Glycemic Control in Type 2 Diabetes: Systematic Review and Meta-analysis.
Menezes Vanessa M, Koller Olívia G, Feoli Ana Maria P et al. · Nutr Rev · 2026
PMID: 40930514Meta-Analysis
Association between SGLT2 inhibitors and genital cancer: a meta-analysis and mendelian randomization study.
Xu Bo, Liu Yilin, He Zunbo et al. · J Endocrinol Invest · 2026
PMID: 40965816Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tolbutamide sodium (substance)
SNOMED CT
109194005
UMLS CUI
C0724709

Clinical Data

This intervention maps to 10 entities in the Healos knowledge graph.

1
Conditions
4
Biomarkers
3
Specialists
0
Symptoms
903
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.